{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:50:47Z","timestamp":1788929447542,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20\u201302\u201300052"],"award-info":[{"award-number":["20\u201302\u201300052"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.biopha.2022.114157","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T17:15:37Z","timestamp":1672161337000},"page":"114157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5\/6 nephrectomized rats with aorto-caval fistula"],"prefix":"10.1016","volume":"158","author":[{"given":"Petr","family":"Kala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Va\u0148ourkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u0160karoupkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Kompanowska-Jezierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Walkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Veselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"T\u00e1borsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Maxov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Van\u011b\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.114157_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure. A contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.114157_bib2","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","author":"Savarese","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.114157_bib3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.114157_bib4","first-page":"1157","article-title":"Cardiovascular disease in chronic kidney disease","volume":"143","author":"Jankowski","year":"2021","journal-title":"Pathophysiol. Insights Ther. Options Circ."},{"key":"10.1016\/j.biopha.2022.114157_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MNH.0000000000000778","article-title":"Can chronic kidney disease lead to chronic heart failure, and does worsening chronic heart failure lead to chronic kidney disease progression","volume":"31","author":"Leon","year":"2022","journal-title":"Curr. Opin. Nehprol Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/diagnostics11112164","article-title":"Chronic kidney disease and heart failure \u2013 everyday diagnostic challenges","volume":"11","author":"Adamska-Welnicka","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.biopha.2022.114157_bib7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.14180920","article-title":"Management of heart failure patient with CKD","volume":"16","author":"Banerjee","year":"2021","journal-title":"CJASN"},{"key":"10.1016\/j.biopha.2022.114157_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfab290","article-title":"The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure","author":"Ortiz","year":"2022","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.biopha.2022.114157_bib9","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.114157_bib10","article-title":"Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy","author":"Abassi","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biopha.2022.114157_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/1440-1681.12419","article-title":"Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula","volume":"42","author":"\u010cervenka","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/10641963.2021.1907398","article-title":"Effects of renal sympathetic denervation on the course of congestive heart failure combined with chronic kidney disease: insight from studies with fawn-hooded hypertensive rats with volume overload induced using aorto-caval fistula","volume":"43","author":"Honetschlagerov\u00e1","year":"2021","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib13","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/cvr\/cvz161","article-title":"Small animals models of heart failure","volume":"115","author":"Riehle","year":"2019","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2022.114157_bib14","first-page":"95","article-title":"A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats","volume":"79","author":"Shimamura","year":"1975","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.114157_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.mnh.0000222691.53970.83","article-title":"Progression of chronic kidney disease: insight from animal models","volume":"15","author":"Zoja","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/1440-1681.12619","article-title":"Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula","volume":"43","author":"\u010cervenka","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cell","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.114157_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000185","article-title":"Endothelin-1 and the kidney: new perspectives and recent findings","volume":"25","author":"De Miguel","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2022.114157_bib20","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 years from discovery to therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.114157_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.peptides.2018.10.002","article-title":"Endothelin and the heart in health and diseases","volume":"111","author":"Miyauchi","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2022.114157_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00467-020-04518-2","article-title":"Endothelin-target new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibition","volume":"36","author":"Benigni","year":"2021","journal-title":"Pedia Nephrol."},{"key":"10.1016\/j.biopha.2022.114157_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodeling and clinical outcomes in EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomized, double-blind, placebo-controlled trial","volume":"364","author":"Anand","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.114157_bib24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2009060593","article-title":"Avosentan for over diabetic nephropathy","volume":"21","author":"Mann","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114157_bib25","first-page":"317","article-title":"Long-term effect on endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure","volume":"5","author":"Packer","year":"2017","journal-title":"Prim. Results ENABLE Trials J. Am. Col. Cardiol. HF"},{"key":"10.1016\/j.biopha.2022.114157_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000504623","article-title":"The role of endothelin and endothelin antagonists in chronic kidney disease","volume":"6","author":"Raina","year":"2020","journal-title":"Kidney Dis."},{"key":"10.1016\/j.biopha.2022.114157_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomized, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.114157_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.lfs.2013.12.018","article-title":"Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic rats","volume":"118","author":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.114157_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/10641963.2016.1235184","article-title":"Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats","volume":"39","author":"Sedl\u00e1kov\u00e1","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/biomedicines9081053","article-title":"Effects of Epoxyeicosatrienoic acid-enhancing therapy on the course of congestive heart failure in angiotensin II-dependent rat hypertension: from mRNA analysis towards functional in vivo evaluation","volume":"9","author":"Kala","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2022.114157_bib31","doi-asserted-by":"crossref","unstructured":"Cohen J. Some issue in power analysis. In: Statistical Power Analysis for Bevavioral Sciences. Cohen J (Ed.). Routlede 2nd edition, 2013, pp. 531\u2013542.","DOI":"10.4324\/9780203771587"},{"key":"10.1016\/j.biopha.2022.114157_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2018030296","article-title":"Sex-related disparities in CKD progression","volume":"30","author":"Ricardo","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.114157_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex differences in heart failure","volume":"28","author":"Lala","year":"2022","journal-title":"J. Cardia Fail"},{"key":"10.1016\/j.biopha.2022.114157_bib34","first-page":"F329","article-title":"Does sex matter?: an update on the implementation of sex as a biological variable in research","volume":"318","author":"Mannon","year":"2020","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib35","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1111\/bph.14761","article-title":"Sex: a change in our guidleines to authors to ensure that this no longer an ignored experimental variable","volume":"176","author":"Docherty","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.114157_bib36","first-page":"H819","article-title":"Reinforcing rigor and reproducibility expectatinos for use of sex and gender in cardiovascular research","volume":"321","author":"Lindsey","year":"2021","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/cvr\/24.5.430","article-title":"Simple, rapid, and effective method of producing aorto-caval shunts in the rat","volume":"24","author":"Garcia","year":"1990","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2022.114157_bib38","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.acthis.2014.08.006","article-title":"Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure","volume":"116","author":"Cohen-Segev","year":"2014","journal-title":"Acta Histiochem."},{"key":"10.1016\/j.biopha.2022.114157_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.hlc.2015.02.023","article-title":"Differential effects of prevention and reversal treatment with Lisinopril on left ventricular remodeling in a rat model of heart failure","volume":"24","author":"Brower","year":"2015","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.biopha.2022.114157_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1159\/000501688","article-title":"Altered renal vascular responsiveness to vasoactive agents in rats with angiotensin II-dependent hypertension and congestive heart failure","volume":"44","author":"Vackov\u00e1","year":"2019","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.biopha.2022.114157_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000336823","article-title":"Effects of combined endothelin A receptor blockade and renin-angiotensin system on the course of end-organ damage in 5\/6 nephrectomized Ren-2 hypertensive rats","volume":"35","author":"Van\u011b\u010dkov\u00e1","year":"2012","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.biopha.2022.114157_bib42","first-page":"H2030","article-title":"Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats","volume":"289","author":"Emter","year":"2005","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000331562","article-title":"The course of heart failure development and mortality in rats with volume overload due to aorto-caval fistula","volume":"35","author":"Melenovsky","year":"2012","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.biopha.2022.114157_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1440-1827.2008.02237.x","article-title":"New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure","volume":"58","author":"Nakano","year":"2008","journal-title":"Pathol. Int."},{"key":"10.1016\/j.biopha.2022.114157_bib45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1440-1681.2010.05453.x","article-title":"Similar renoprotection after renin-angiotensin-dependent and \u2013independent antihypertensive therapy in 5\/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?","volume":"37","author":"Kujal","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib46","first-page":"299","article-title":"Recommendation for blood pressure measurements in humans and experimental animals. Part 2","volume":"45","author":"Kurtz","year":"2005","journal-title":"Blood Press. Meas. Exp. Anim. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib47","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/HYPERTENSIONAHA.107.100750","article-title":"Age- and sodium-sensitive hypertension and sex-dependent renal changes in rats with a reduced nephron number","volume":"51","author":"Salazar","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2022.114157_bib48","first-page":"H523","article-title":"Schwartzkopf ChD, Buys ES, Masferrer JL, Salazar FJ. SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet","volume":"322","author":"Reverte","year":"2022","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2022.114157_bib49","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000487902","article-title":"Combined inhibition of soluble epoxide hydrolase and renin-angiotensin system exhibits superior renoprotection to renin-angiotensin system blockade in 5\/6 nephrectomized Ren-2 transgenic hypertensive rats with established chronic kidney disease","volume":"43","author":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","year":"2018","journal-title":"Kidney Blood Press Res."},{"key":"10.1016\/j.biopha.2022.114157_bib50","article-title":"Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension","author":"Kala","year":"2022","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.33549\/physiolres.933607","article-title":"The dilemma of dual renin-angiotensin system blockade in chronic kidney disease: why beneficial in animal experiments but not in the clinic?","volume":"66","author":"\u010cert\u00edkov\u00e1 Ch\u00e1bov\u00e1","year":"2017","journal-title":"Physiol. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2022.114157_bib52","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.33549\/physiolres.933898","article-title":"Renoprotective effects of ETA receptor antagonists therapy in experimental non-diabetic chronic kidney disease: is there still hope for the future?","volume":"67","author":"Van\u011b\u010dkov\u00e1","year":"2018","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biopha.2022.114157_bib53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MNH.0000000000000716","article-title":"Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease","volume":"30","author":"Smeijer","year":"2021","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.biopha.2022.114157_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.116.234930","article-title":"receptor blockade, aby activating ETB receptors increases vascular permeability and induces exaggerated fluid retention","volume":"361","author":"Vercauteren","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.114157_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.665831","article-title":"Albuminuria and dipstick proteinuria for predicting mortality in heart failure: a systematic review and meta-analyses","volume":"8","author":"Liang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"Supplement A","key":"10.1016\/j.biopha.2022.114157_bib56","article-title":"The epidemiology of heart failure: the Framighan study","volume":"22","author":"Ho","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2022.114157_bib57","first-page":"543","article-title":"The transition from hypertension to heart failure","volume":"8","author":"Messerli","year":"2017","journal-title":"JACC: Heart Fail."},{"key":"10.1016\/j.biopha.2022.114157_bib58","first-page":"13","article-title":"Proteinuria and its relation to cardiovascular disease","volume":"7","author":"Currie","year":"2014","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.biopha.2022.114157_bib59","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ekir.2019.08.007","article-title":"Implementing the Kidney Health Initiative surrogate efficacy endpoint in patients with IgA nephropathy (the PROTECT trial)","volume":"4","author":"Barratt","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2022.114157_bib60","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ekir.2019.12.017","article-title":"Study design of the phase 3 sparsentan versus irbesartan (DUPLEX) study in patients with focal segmental glomerulosclerosis","volume":"5","author":"Komers","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.biopha.2022.114157_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00365510802145059","article-title":"Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury","volume":"241","author":"Bonventre","year":"2008","journal-title":"Scand. J. Clinc Lab Invest."},{"key":"10.1016\/j.biopha.2022.114157_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11255-009-9608-z","article-title":"NGAL: a biomarker of acute kidney injury and other systemic conditions","volume":"42","author":"Soni","year":"2010","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.biopha.2022.114157_bib63","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCRESAHA.122.321368","article-title":"The growing importance of basic models of cardiovascular disease","volume":"130","author":"Rosenzweig","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2022.114157_bib64","series-title":"An Introduction To The Study Of Experimental Medicine","author":"Bernard","year":"2018"},{"key":"10.1016\/j.biopha.2022.114157_bib65","first-page":"508","article-title":"Endothelin receptor antagonists and risk of heart failure in CKD. Balancing the cardiorenal axis","volume":"10","author":"Neuen","year":"2022","journal-title":"J. Am. Coll. Cardiol. HF"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222015463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:35:14Z","timestamp":1779795314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222015463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":65,"alternative-id":["S0753332222015463"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114157","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5\/6 nephrectomized rats with aorto-caval fistula","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114157"}}